D
Aclaris Therapeutics, Inc. ACRS
$1.75 -$0.06-3.32% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -129.47% -68.53% -49.26% 67.72% 44.28%
Total Depreciation and Amortization -39.48% -23.79% -6.49% 8.12% 16.65%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3,314.14% 8,278.65% 104,538.54% -122.81% -110.68%
Change in Net Operating Assets 755.29% 276.42% 16.33% 437.31% -386.31%
Cash from Operations 84.50% 83.08% 74.37% 80.26% 12.83%
Capital Expenditure 90.09% 96.75% 90.76% 42.24% 37.82%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -208.45% -276.83% -246.54% -36.08% 412.79%
Cash from Investing -209.81% -281.14% -250.95% -35.94% 459.35%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 8,892.36% 189.61% 189.61% -96.62% -96.68%
Repurchase of Common Stock -273.21% -300.64% -300.98% 25.49% -1,427.27%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -515.86% -515.86% -515.86% -- --
Cash from Financing 71,559.62% 178.85% 179.10% -99.98% -100.39%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 130.88% 38.25% -183.53% 138.08% 77.59%